ResMed expands in a lucrative niche

Article Excerpt

ResMed continues to prosper in its CPAP machine market but is also expanding quickly in out-of-hospital software solutions. These are aimed at letting healthcare agencies work more efficiently to provide individualized service to patients. This is a big growth area, and ResMed’s progress here bodes well for its share price and for its investors. We still believe in this leader’s strong prospects and its outlook. It’s a Power Buy. RESMED INC., $236.41, is a Power Buy. The company (New York symbol RMD; TSINetwork Rating: Average) (www.resmed.com; Shares outstanding: 146.3 million; Market cap: $34.5 billion; Dividend yield: 0.7%) operates in two main segments: The Sleep and Respiratory Care segment primarily makes and sells CPAP (nasal continuous positive airway pressure) medical devices. They are used to treat patients with sleep apnea and more. With each new machine ResMed sells, it acquires a potential long-term replacement-parts customer: the tubing, masks and so on for each device need replacement several times a year. That provides steady, recurring revenue. At the same time, the company’s devices increasingly collect data from…